BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 965 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $891,000 | -35.6% | 11,068 | -32.5% | 0.04% | -20.8% |
Q1 2021 | $1,383,000 | -14.2% | 16,394 | -18.4% | 0.05% | -2.0% |
Q4 2020 | $1,612,000 | -50.9% | 20,103 | -50.8% | 0.05% | -38.8% |
Q3 2020 | $3,286,000 | -18.7% | 40,862 | -13.1% | 0.08% | -45.9% |
Q2 2020 | $4,044,000 | +1.0% | 47,000 | -4.9% | 0.15% | -14.0% |
Q1 2020 | $4,004,000 | -43.6% | 49,400 | -41.9% | 0.17% | -28.0% |
Q4 2019 | $7,101,000 | -14.5% | 85,000 | -10.5% | 0.24% | -22.1% |
Q3 2019 | $8,305,000 | -40.0% | 95,000 | -43.8% | 0.31% | -40.0% |
Q2 2019 | $13,836,000 | +12.7% | 169,000 | +11.9% | 0.51% | +7.6% |
Q1 2019 | $12,281,000 | +273.1% | 151,000 | +202.0% | 0.48% | +247.4% |
Q4 2018 | $3,292,000 | -32.2% | 50,000 | -20.6% | 0.14% | -8.1% |
Q3 2018 | $4,857,000 | -65.9% | 63,000 | -67.4% | 0.15% | -67.6% |
Q2 2018 | $14,249,000 | +121.3% | 193,000 | +94.9% | 0.46% | +96.6% |
Q1 2018 | $6,440,000 | +77.9% | 99,000 | +76.8% | 0.23% | +81.4% |
Q4 2017 | $3,620,000 | -61.8% | 56,000 | -62.9% | 0.13% | -61.6% |
Q3 2017 | $9,474,000 | +3.7% | 151,000 | 0.0% | 0.34% | 0.0% |
Q2 2017 | $9,140,000 | +155.4% | 151,000 | +118.8% | 0.34% | +147.1% |
Q1 2017 | $3,578,000 | +16.9% | 69,000 | 0.0% | 0.14% | +18.3% |
Q4 2016 | $3,060,000 | -33.0% | 69,000 | -28.1% | 0.12% | -34.7% |
Q3 2016 | $4,569,000 | -19.8% | 96,000 | -23.8% | 0.18% | -22.5% |
Q2 2016 | $5,696,000 | +77.7% | 126,000 | +61.5% | 0.23% | +76.0% |
Q1 2016 | $3,205,000 | +7.8% | 78,000 | 0.0% | 0.13% | +5.7% |
Q4 2015 | $2,974,000 | +16.1% | 78,000 | 0.0% | 0.12% | +6.1% |
Q3 2015 | $2,562,000 | -53.0% | 78,000 | 0.0% | 0.12% | -43.9% |
Q2 2015 | $5,451,000 | +2.1% | 78,000 | 0.0% | 0.20% | +20.6% |
Q1 2015 | $5,341,000 | -13.2% | 78,000 | -7.1% | 0.17% | +9.0% |
Q4 2014 | $6,156,000 | +40.7% | 84,000 | +37.7% | 0.16% | +23.8% |
Q3 2014 | $4,376,000 | -0.7% | 61,000 | 0.0% | 0.13% | -9.4% |
Q2 2014 | $4,409,000 | -1.8% | 61,000 | 0.0% | 0.14% | -6.7% |
Q1 2014 | $4,488,000 | – | 61,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |